Study of SFRP1 and SFRP2 methylation status in patients with de novo Acute Myeloblastic Leukemia
- PMID: 25802696
- PMCID: PMC4369229
Study of SFRP1 and SFRP2 methylation status in patients with de novo Acute Myeloblastic Leukemia
Abstract
Intoduction: Acute myeloid leukemia (AML) is a heterogeneous group of hematologic malignancies with abundant changeability in the pathogenesis. DNA methylation of CpG islands within the promoters of specific genes may play roles in tumor initiation and progression. Secreted frizzled-related proteins (SFRPs) are negative regulator of the Wnt signaling pathway. In the present study, we examined the methylation status of SFRP1 and SFRP2 genes in patients with AML.
Methods: Isolated DNA from peripheral blood of 43 AML patients and 25 healthy subjects as a control group was treated with sodium bisulfite was treated with sodium bisulfite and analyzed by methylation-specific polymerase chain reaction (MSP) with primers specific for methylated and unmethylated promoter sequences of the SFRP1 & -2 genes. We used Mann-Whitney u-tests to investigate the correlation between SFRP1 and SFRP2 genes hypermethylation and clinical parameters.
Results: The frequency of aberrant hypermethylation of SFRP1 and SFRP2 genes in patients with AML was determined 30.2% (13/43) and 20.9% (9/43), respectively. In addition, for all subjects in control group, methylation of SFRP1 and SFRP2 genes were negative. Patients with M0 subtype of FAB-AML had the highest incidence of hypermethylation of SFRP1 (P = 0.028) and SFRP2 (P = 0.004).
Conclusion: The present study showed that, like many solid tumors, methylation of SFRP genes also occurs in AML. Therefore, the methylation of these genes may play a role in the initiation of leukmogenesis.
Keywords: AML; DNA Methylation; SFRP.
Figures
References
-
- Lowenberg B, Downing JR, Burnett A. Acute myeloid leukemia. New England Journal of Medicine. 1999; 341( 14): 1051– 62. - PubMed
-
- Parkin D, Whelan S, Ferlay J, et al. Cancer incidence in five continents Vol. VIII. IARC scientific publications. 2002; 155. - PubMed
-
- Jost E, Schmid J, Wilop S, et al. Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia. British journal of haematology. 2008; 142( 5): 745– 53. - PubMed
-
- Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nature Reviews Cancer. 2008; 8( 5): 387– 98. - PubMed
-
- Jamieson CH, Ailles LE, Dylla SJ, et al. Granulocyte–macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. New England Journal of Medicine. 2004; 351( 7): 657– 67. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials